Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B

Hyperprolactinemia and hyperleptinemia occur during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) through the activation of JAK-2/STAT-3 signaling pathway in hypothalamic paraventricular nu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of endocrinology 2007-11, Vol.195 (2), p.341-350
Hauptverfasser: Roy, A F, Benomar, Y, Bailleux, V, Vacher, C M, Aubourg, A, Gertler, A, Djiane, J, Taouis, M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 350
container_issue 2
container_start_page 341
container_title Journal of endocrinology
container_volume 195
creator Roy, A F
Benomar, Y
Bailleux, V
Vacher, C M
Aubourg, A
Gertler, A
Djiane, J
Taouis, M
description Hyperprolactinemia and hyperleptinemia occur during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) through the activation of JAK-2/STAT-3 signaling pathway in hypothalamic paraventricular nucleus (PVN) leading to hyperphagia. PRL may also act through the inhibition of anorexigenic effect of leptin via induction of suppressor of cytokine signaling 3 (SOCS-3). This paper aimed to co-localize PRL (PRL-R) and leptin (ObRb) receptors in the hypothalamus of female rats and investigate the possible cross-desensitization between PRL-R and ObRb. We showed that: 1) PRL-R and ObRb are expressed in the PVN and co-localized in the same neurons; 2) in lactating females leptin failed to activate JAK-2/STAT-3 signaling pathway; 3) in Chinese Hamster Ovary (CHO) stably co-expressing PRL-R and ObRb, overexposure to PRL did not affect leptin signaling but totally abolished PRL-dependent STAT-5 phosphorylation. The overexposure to leptin produces similar results with strong alteration of leptin-dependent STAT-3 phosphorylation, whereas PRL-dependent STAT-5 was not affected; and 4) CHO-ObRb/PRL-R cells overexposure to leptin or PRL induces the expression of negative regulators SOCS-3 and PTP-1B. Thus, we conclude that these negative regulators affect specifically the inducer signaling pathway; for instance, SOCS-3 induced by PRL will affect PRL-R signaling but not ObRb signaling and vice versa. Finally, the lack of cross-desensitization between PURL-R and ObRb suggests that hyperphagia observed during gestation and lactation may be attributed to a direct effect of PRL on NPYexpression, and is most likely exacerbated by the physiological leptin resistance state.
doi_str_mv 10.1677/JOE-07-0321
format Article
fullrecord <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_02664466v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68417793</sourcerecordid><originalsourceid>FETCH-LOGICAL-b4851-aa0f2b444fd0f6c30f7d77ca87f1e287f81cbdf019c061296e4692a4b72869273</originalsourceid><addsrcrecordid>eNqFkk1v1DAQhiMEokvhxB35AhJCAdtx7ORYqkJBK7WHcrYmznjXNOuE2Mtq-R38YJzdQCsOcPHH-Jl3xn6dZc8ZfcukUu8-X13kVOW04OxBtmBC1bmsaPkwW1DKeTqqy5PsSQhfKWUlU8Xj7ISlGCtFuch-LsHckt4SM_Yh5C0G9MFF9wOi6z1pMO4QPelwiM4T8C0Zxr4DM-2CW3nonF-RAeJ6B_tAUv7gIpK4RuJ8uzUHlSQftsMwYgj9eCi2j_2t83hPojiIX99c5-z90-yRhS7gs3k-zb58uLg5v8yXVx8_nZ8t80ZUJcsBqOWNEMK21EpTUKtapQxUyjLkaayYaVpLWW2oZLyWKGTNQTSKV2mhitPs9VF3DZ0eRreBca97cPrybKmnGOVSCiHld5bYV0c23f_bFkPUGxcMdh147LdBy0owperivyCngnGuJsU3R_Dw9CPaPy0wqidndXJWU6UnZxP9YpbdNhts79jZygS8nAEIBjo7gjcu3HE155yWMnF8vrRbrXduRN24PhiHPjrrDNyv_vtfpSR2TPqL_VfHvwB8M8xr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20412271</pqid></control><display><type>article</type><title>Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Roy, A F ; Benomar, Y ; Bailleux, V ; Vacher, C M ; Aubourg, A ; Gertler, A ; Djiane, J ; Taouis, M</creator><creatorcontrib>Roy, A F ; Benomar, Y ; Bailleux, V ; Vacher, C M ; Aubourg, A ; Gertler, A ; Djiane, J ; Taouis, M</creatorcontrib><description>Hyperprolactinemia and hyperleptinemia occur during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) through the activation of JAK-2/STAT-3 signaling pathway in hypothalamic paraventricular nucleus (PVN) leading to hyperphagia. PRL may also act through the inhibition of anorexigenic effect of leptin via induction of suppressor of cytokine signaling 3 (SOCS-3). This paper aimed to co-localize PRL (PRL-R) and leptin (ObRb) receptors in the hypothalamus of female rats and investigate the possible cross-desensitization between PRL-R and ObRb. We showed that: 1) PRL-R and ObRb are expressed in the PVN and co-localized in the same neurons; 2) in lactating females leptin failed to activate JAK-2/STAT-3 signaling pathway; 3) in Chinese Hamster Ovary (CHO) stably co-expressing PRL-R and ObRb, overexposure to PRL did not affect leptin signaling but totally abolished PRL-dependent STAT-5 phosphorylation. The overexposure to leptin produces similar results with strong alteration of leptin-dependent STAT-3 phosphorylation, whereas PRL-dependent STAT-5 was not affected; and 4) CHO-ObRb/PRL-R cells overexposure to leptin or PRL induces the expression of negative regulators SOCS-3 and PTP-1B. Thus, we conclude that these negative regulators affect specifically the inducer signaling pathway; for instance, SOCS-3 induced by PRL will affect PRL-R signaling but not ObRb signaling and vice versa. Finally, the lack of cross-desensitization between PURL-R and ObRb suggests that hyperphagia observed during gestation and lactation may be attributed to a direct effect of PRL on NPYexpression, and is most likely exacerbated by the physiological leptin resistance state.</description><identifier>ISSN: 0022-0795</identifier><identifier>EISSN: 1479-6805</identifier><identifier>DOI: 10.1677/JOE-07-0321</identifier><identifier>PMID: 17951545</identifier><identifier>CODEN: JOENAK</identifier><language>eng</language><publisher>Colchester: BioScientifica</publisher><subject>Animals ; Biological and medical sciences ; CHO Cells ; Cricetinae ; Cricetulus ; Drug Administration Schedule ; Drug Resistance ; Endocrinology and metabolism ; Female ; Fundamental and applied biological sciences. Psychology ; Hormones and neuropeptides. Regulation ; Human health and pathology ; Hypothalamus. Hypophysis. Epiphysis. Urophysis ; Janus Kinase 2 - metabolism ; Lactation - physiology ; Leptin - administration &amp; dosage ; Leptin - metabolism ; Leptin - pharmacology ; Life Sciences ; Mice ; Paraventricular Hypothalamic Nucleus - metabolism ; Phosphorylation - drug effects ; Prolactin - administration &amp; dosage ; Prolactin - metabolism ; Prolactin - pharmacology ; Protein Tyrosine Phosphatase, Non-Receptor Type 1 - biosynthesis ; Rats ; Receptors, Leptin - genetics ; Receptors, Leptin - metabolism ; Receptors, Prolactin - genetics ; Receptors, Prolactin - metabolism ; Regular papers ; Signal Transduction - physiology ; STAT3 Transcription Factor - metabolism ; STAT5 Transcription Factor - metabolism ; Suppressor of Cytokine Signaling 3 Protein ; Suppressor of Cytokine Signaling Proteins - biosynthesis ; Tissue Distribution ; Transfection ; Vertebrates: endocrinology</subject><ispartof>Journal of endocrinology, 2007-11, Vol.195 (2), p.341-350</ispartof><rights>Society for Endocrinology</rights><rights>2008 INIST-CNRS</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b4851-aa0f2b444fd0f6c30f7d77ca87f1e287f81cbdf019c061296e4692a4b72869273</citedby><orcidid>0000-0002-4101-691X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=19222056$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17951545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.inrae.fr/hal-02664466$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Roy, A F</creatorcontrib><creatorcontrib>Benomar, Y</creatorcontrib><creatorcontrib>Bailleux, V</creatorcontrib><creatorcontrib>Vacher, C M</creatorcontrib><creatorcontrib>Aubourg, A</creatorcontrib><creatorcontrib>Gertler, A</creatorcontrib><creatorcontrib>Djiane, J</creatorcontrib><creatorcontrib>Taouis, M</creatorcontrib><title>Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B</title><title>Journal of endocrinology</title><addtitle>J Endocrinol</addtitle><description>Hyperprolactinemia and hyperleptinemia occur during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) through the activation of JAK-2/STAT-3 signaling pathway in hypothalamic paraventricular nucleus (PVN) leading to hyperphagia. PRL may also act through the inhibition of anorexigenic effect of leptin via induction of suppressor of cytokine signaling 3 (SOCS-3). This paper aimed to co-localize PRL (PRL-R) and leptin (ObRb) receptors in the hypothalamus of female rats and investigate the possible cross-desensitization between PRL-R and ObRb. We showed that: 1) PRL-R and ObRb are expressed in the PVN and co-localized in the same neurons; 2) in lactating females leptin failed to activate JAK-2/STAT-3 signaling pathway; 3) in Chinese Hamster Ovary (CHO) stably co-expressing PRL-R and ObRb, overexposure to PRL did not affect leptin signaling but totally abolished PRL-dependent STAT-5 phosphorylation. The overexposure to leptin produces similar results with strong alteration of leptin-dependent STAT-3 phosphorylation, whereas PRL-dependent STAT-5 was not affected; and 4) CHO-ObRb/PRL-R cells overexposure to leptin or PRL induces the expression of negative regulators SOCS-3 and PTP-1B. Thus, we conclude that these negative regulators affect specifically the inducer signaling pathway; for instance, SOCS-3 induced by PRL will affect PRL-R signaling but not ObRb signaling and vice versa. Finally, the lack of cross-desensitization between PURL-R and ObRb suggests that hyperphagia observed during gestation and lactation may be attributed to a direct effect of PRL on NPYexpression, and is most likely exacerbated by the physiological leptin resistance state.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>CHO Cells</subject><subject>Cricetinae</subject><subject>Cricetulus</subject><subject>Drug Administration Schedule</subject><subject>Drug Resistance</subject><subject>Endocrinology and metabolism</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hormones and neuropeptides. Regulation</subject><subject>Human health and pathology</subject><subject>Hypothalamus. Hypophysis. Epiphysis. Urophysis</subject><subject>Janus Kinase 2 - metabolism</subject><subject>Lactation - physiology</subject><subject>Leptin - administration &amp; dosage</subject><subject>Leptin - metabolism</subject><subject>Leptin - pharmacology</subject><subject>Life Sciences</subject><subject>Mice</subject><subject>Paraventricular Hypothalamic Nucleus - metabolism</subject><subject>Phosphorylation - drug effects</subject><subject>Prolactin - administration &amp; dosage</subject><subject>Prolactin - metabolism</subject><subject>Prolactin - pharmacology</subject><subject>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - biosynthesis</subject><subject>Rats</subject><subject>Receptors, Leptin - genetics</subject><subject>Receptors, Leptin - metabolism</subject><subject>Receptors, Prolactin - genetics</subject><subject>Receptors, Prolactin - metabolism</subject><subject>Regular papers</subject><subject>Signal Transduction - physiology</subject><subject>STAT3 Transcription Factor - metabolism</subject><subject>STAT5 Transcription Factor - metabolism</subject><subject>Suppressor of Cytokine Signaling 3 Protein</subject><subject>Suppressor of Cytokine Signaling Proteins - biosynthesis</subject><subject>Tissue Distribution</subject><subject>Transfection</subject><subject>Vertebrates: endocrinology</subject><issn>0022-0795</issn><issn>1479-6805</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkk1v1DAQhiMEokvhxB35AhJCAdtx7ORYqkJBK7WHcrYmznjXNOuE2Mtq-R38YJzdQCsOcPHH-Jl3xn6dZc8ZfcukUu8-X13kVOW04OxBtmBC1bmsaPkwW1DKeTqqy5PsSQhfKWUlU8Xj7ISlGCtFuch-LsHckt4SM_Yh5C0G9MFF9wOi6z1pMO4QPelwiM4T8C0Zxr4DM-2CW3nonF-RAeJ6B_tAUv7gIpK4RuJ8uzUHlSQftsMwYgj9eCi2j_2t83hPojiIX99c5-z90-yRhS7gs3k-zb58uLg5v8yXVx8_nZ8t80ZUJcsBqOWNEMK21EpTUKtapQxUyjLkaayYaVpLWW2oZLyWKGTNQTSKV2mhitPs9VF3DZ0eRreBca97cPrybKmnGOVSCiHld5bYV0c23f_bFkPUGxcMdh147LdBy0owperivyCngnGuJsU3R_Dw9CPaPy0wqidndXJWU6UnZxP9YpbdNhts79jZygS8nAEIBjo7gjcu3HE155yWMnF8vrRbrXduRN24PhiHPjrrDNyv_vtfpSR2TPqL_VfHvwB8M8xr</recordid><startdate>200711</startdate><enddate>200711</enddate><creator>Roy, A F</creator><creator>Benomar, Y</creator><creator>Bailleux, V</creator><creator>Vacher, C M</creator><creator>Aubourg, A</creator><creator>Gertler, A</creator><creator>Djiane, J</creator><creator>Taouis, M</creator><general>BioScientifica</general><general>Portland Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-4101-691X</orcidid></search><sort><creationdate>200711</creationdate><title>Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B</title><author>Roy, A F ; Benomar, Y ; Bailleux, V ; Vacher, C M ; Aubourg, A ; Gertler, A ; Djiane, J ; Taouis, M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b4851-aa0f2b444fd0f6c30f7d77ca87f1e287f81cbdf019c061296e4692a4b72869273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>CHO Cells</topic><topic>Cricetinae</topic><topic>Cricetulus</topic><topic>Drug Administration Schedule</topic><topic>Drug Resistance</topic><topic>Endocrinology and metabolism</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hormones and neuropeptides. Regulation</topic><topic>Human health and pathology</topic><topic>Hypothalamus. Hypophysis. Epiphysis. Urophysis</topic><topic>Janus Kinase 2 - metabolism</topic><topic>Lactation - physiology</topic><topic>Leptin - administration &amp; dosage</topic><topic>Leptin - metabolism</topic><topic>Leptin - pharmacology</topic><topic>Life Sciences</topic><topic>Mice</topic><topic>Paraventricular Hypothalamic Nucleus - metabolism</topic><topic>Phosphorylation - drug effects</topic><topic>Prolactin - administration &amp; dosage</topic><topic>Prolactin - metabolism</topic><topic>Prolactin - pharmacology</topic><topic>Protein Tyrosine Phosphatase, Non-Receptor Type 1 - biosynthesis</topic><topic>Rats</topic><topic>Receptors, Leptin - genetics</topic><topic>Receptors, Leptin - metabolism</topic><topic>Receptors, Prolactin - genetics</topic><topic>Receptors, Prolactin - metabolism</topic><topic>Regular papers</topic><topic>Signal Transduction - physiology</topic><topic>STAT3 Transcription Factor - metabolism</topic><topic>STAT5 Transcription Factor - metabolism</topic><topic>Suppressor of Cytokine Signaling 3 Protein</topic><topic>Suppressor of Cytokine Signaling Proteins - biosynthesis</topic><topic>Tissue Distribution</topic><topic>Transfection</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roy, A F</creatorcontrib><creatorcontrib>Benomar, Y</creatorcontrib><creatorcontrib>Bailleux, V</creatorcontrib><creatorcontrib>Vacher, C M</creatorcontrib><creatorcontrib>Aubourg, A</creatorcontrib><creatorcontrib>Gertler, A</creatorcontrib><creatorcontrib>Djiane, J</creatorcontrib><creatorcontrib>Taouis, M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Journal of endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roy, A F</au><au>Benomar, Y</au><au>Bailleux, V</au><au>Vacher, C M</au><au>Aubourg, A</au><au>Gertler, A</au><au>Djiane, J</au><au>Taouis, M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B</atitle><jtitle>Journal of endocrinology</jtitle><addtitle>J Endocrinol</addtitle><date>2007-11</date><risdate>2007</risdate><volume>195</volume><issue>2</issue><spage>341</spage><epage>350</epage><pages>341-350</pages><issn>0022-0795</issn><eissn>1479-6805</eissn><coden>JOENAK</coden><abstract>Hyperprolactinemia and hyperleptinemia occur during gestation and lactation with marked hyperphagia associated with leptin resistance. Prolactin (PRL) induces the expression of orexigenic neuropeptide Y (NPY) through the activation of JAK-2/STAT-3 signaling pathway in hypothalamic paraventricular nucleus (PVN) leading to hyperphagia. PRL may also act through the inhibition of anorexigenic effect of leptin via induction of suppressor of cytokine signaling 3 (SOCS-3). This paper aimed to co-localize PRL (PRL-R) and leptin (ObRb) receptors in the hypothalamus of female rats and investigate the possible cross-desensitization between PRL-R and ObRb. We showed that: 1) PRL-R and ObRb are expressed in the PVN and co-localized in the same neurons; 2) in lactating females leptin failed to activate JAK-2/STAT-3 signaling pathway; 3) in Chinese Hamster Ovary (CHO) stably co-expressing PRL-R and ObRb, overexposure to PRL did not affect leptin signaling but totally abolished PRL-dependent STAT-5 phosphorylation. The overexposure to leptin produces similar results with strong alteration of leptin-dependent STAT-3 phosphorylation, whereas PRL-dependent STAT-5 was not affected; and 4) CHO-ObRb/PRL-R cells overexposure to leptin or PRL induces the expression of negative regulators SOCS-3 and PTP-1B. Thus, we conclude that these negative regulators affect specifically the inducer signaling pathway; for instance, SOCS-3 induced by PRL will affect PRL-R signaling but not ObRb signaling and vice versa. Finally, the lack of cross-desensitization between PURL-R and ObRb suggests that hyperphagia observed during gestation and lactation may be attributed to a direct effect of PRL on NPYexpression, and is most likely exacerbated by the physiological leptin resistance state.</abstract><cop>Colchester</cop><pub>BioScientifica</pub><pmid>17951545</pmid><doi>10.1677/JOE-07-0321</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-4101-691X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-0795
ispartof Journal of endocrinology, 2007-11, Vol.195 (2), p.341-350
issn 0022-0795
1479-6805
language eng
recordid cdi_hal_primary_oai_HAL_hal_02664466v1
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Animals
Biological and medical sciences
CHO Cells
Cricetinae
Cricetulus
Drug Administration Schedule
Drug Resistance
Endocrinology and metabolism
Female
Fundamental and applied biological sciences. Psychology
Hormones and neuropeptides. Regulation
Human health and pathology
Hypothalamus. Hypophysis. Epiphysis. Urophysis
Janus Kinase 2 - metabolism
Lactation - physiology
Leptin - administration & dosage
Leptin - metabolism
Leptin - pharmacology
Life Sciences
Mice
Paraventricular Hypothalamic Nucleus - metabolism
Phosphorylation - drug effects
Prolactin - administration & dosage
Prolactin - metabolism
Prolactin - pharmacology
Protein Tyrosine Phosphatase, Non-Receptor Type 1 - biosynthesis
Rats
Receptors, Leptin - genetics
Receptors, Leptin - metabolism
Receptors, Prolactin - genetics
Receptors, Prolactin - metabolism
Regular papers
Signal Transduction - physiology
STAT3 Transcription Factor - metabolism
STAT5 Transcription Factor - metabolism
Suppressor of Cytokine Signaling 3 Protein
Suppressor of Cytokine Signaling Proteins - biosynthesis
Tissue Distribution
Transfection
Vertebrates: endocrinology
title Lack of cross-desensitization between leptin and prolactin signaling pathways despite the induction of suppressor of cytokine signaling 3 and PTP-1B
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T07%3A13%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20cross-desensitization%20between%20leptin%20and%20prolactin%20signaling%20pathways%20despite%20the%20induction%20of%20suppressor%20of%20cytokine%20signaling%203%20and%20PTP-1B&rft.jtitle=Journal%20of%20endocrinology&rft.au=Roy,%20A%20F&rft.date=2007-11&rft.volume=195&rft.issue=2&rft.spage=341&rft.epage=350&rft.pages=341-350&rft.issn=0022-0795&rft.eissn=1479-6805&rft.coden=JOENAK&rft_id=info:doi/10.1677/JOE-07-0321&rft_dat=%3Cproquest_hal_p%3E68417793%3C/proquest_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20412271&rft_id=info:pmid/17951545&rfr_iscdi=true